Meet our team

Annika is BioReperias CEO since March 1, 2021 and is responsible for the overall management of the company.She has a long and broad experience from the Pharmaceutical industry and mainly from the field of oncology.

Anna is responsible for business development and strategic partnerships. She is happy to discuss how our services in drug discovery and precision medicine can help your business grow.

Lasse is responsible for technology development using innovative zebrafish technologies. Reach out to him with questions about how our services for drug discovery can help your selection of lead compounds or about how to use our services for clinical trials.

Anna is responsible for coordinating the clinical operations, quality assurance, and quality control. She is responsible for our ongoing strategic partnerships, including managing the company's customer relations.

Malin is responsible for sales and business development at BioReperia, including managing the company's customer relations.

Zaheer is responsible for R & D projects at BioReperia, including management and coordination of clinical studies and partnerships and establishing and maintaining quality assurance for new and existing products.

Gaby is responsible for customer projects at BioReperia, including managment and coordination of clinical studies and partnerships and establishing and maintaining quality assurance for new and existing products.

Elinore is responsible for the management and coordination of quality and regulatory requirements, including managing and maintaining our Quality Management System.

Ali is co-responsible for managing clients and partnerships.He has a broad experience and expertise within the field ofradiation oncology and immunology.